Darbepoetin alfa biosimilar (Hetero Drugs)

阿法达贝泊汀生物类似药 (Hetero Drugs)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDarbepoetin alfa biosimilar (Hetero Drugs)

Drug Alias Name达促红素α生物仿制药 (Hetero Drugs)达依泊汀α生物仿制药 (Hetero Drugs)阿法达贝泊汀生物仿制药 (Hetero Drugs)达贝泊汀α生物仿制药 (Hetero Drugs)阿法达贝汀生物仿制药 (Hetero Drugs) +[6]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsAnemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesHetero Drugs Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsAnemia

Inactive IndicationsN/A

ATC CodeB03XA02